Abstract: The present technology is directed to identifying neutrophil extracellular traps (NETs) in blood. For example, the present technology provides artificial intelligence systems, architectures, and/or programs that can rapidly and/or automatically identify and/or enumerate NETs in peripheral blood smears, CBC scattergrams, and the like. The artificial intelligence architectures can be integrated into current automated imaging and/or analysis systems (e.g., automated imaging systems for performing cell blood counts (CBC)). The artificial intelligence architectures can also be integrated into another computing device, such as a mobile device.